Antonio Roberto Lucena-Araujo
Overview
Explore the profile of Antonio Roberto Lucena-Araujo including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
24
Citations
138
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Berti A, de Castro V, Arcanjo G, Araujo A, Lucena-Araujo A, Bezerra M, et al.
Sci Rep
. 2024 Dec;
14(1):31562.
PMID: 39738165
Sickle cell anemia (SCA) is a monogenic blood disease with complex and multifactorial pathophysiology. The endocannabinoid system (ECS) could be a candidate for modulating SCA complications, such as priapism, as...
2.
Costa D, Filiu-Braga L, Silva-Carvalho A, Schiavinato J, Vasconcelos M, Lobo de Figueiredo-Pontes L, et al.
Leuk Lymphoma
. 2022 Aug;
63(13):3227-3231.
PMID: 36016463
No abstract available.
3.
Vicari H, Coelho-Silva J, Pereira-Martins D, Lucena-Araujo A, Lima K, Lipreri da Silva J, et al.
Invest New Drugs
. 2021 Nov;
40(2):438-452.
PMID: 34837603
Stathmin 1 (STMN1) is a microtubule-destabilizing protein highly expressed in hematological malignancies and involved in proliferation and differentiation. Although a previous study found that the PML-RARα fusion protein, which contributes...
4.
Chenou F, Hounkpe B, Domingos I, Tonasse W, Batista T, Santana R, et al.
Ann Hematol
. 2021 Aug;
100(11):2669-2676.
PMID: 34453189
Intravascular hemolysis (IH) contributes to the development of endothelial dysfunction (ED) in sickle cell anemia (SCA), and the effects of hydroxyurea (HU, the only approved drug that decreases the frequency...
5.
Hatzlhofer B, Pereira-Martins D, Domingos I, Arcanjo G, Weinhauser I, Falcao D, et al.
Ann Hematol
. 2021 Feb;
100(4):921-931.
PMID: 33586016
Alpha thalassemia and beta-globin haplotype are considered classical genetic disease modifiers in sickle cell anemia (SCA) causing clinical heterogeneity. Nevertheless, their functional impact on SCA disease emergence and progression remains...
6.
Maciel N, Filiu-Braga L, Neves F, Rego E, Lucena-Araujo A, Saldanha-Araujo F
Biomark Res
. 2021 Feb;
9(1):10.
PMID: 33541423
Experimental evidence points to the role of Zinc fingers and homeoboxes protein 1 and 2 (ZHX1 and ZHX2) in the development and progression of several types of cancer, including hematological...
7.
Hounkpe B, Chenou F, Domingos I, Cardoso E, Sobreira M, Araujo A, et al.
Res Pract Thromb Haemost
. 2021 Feb;
5(1):204-210.
PMID: 33537545
Background: Recent evidence suggests that generation of neutrophil extracellular traps (NETosis), one of the components of immunothrombosis, is associated with the pathogenesis of both venous thromboembolism and sickle cell disease...
8.
Santaterra V, Fiusa M, Hounkpe B, Chenou F, Tonasse W, da Costa L, et al.
Front Immunol
. 2020 Dec;
11:535147.
PMID: 33381108
Free extracellular heme has been shown to activate several compartments of innate immunity, acting as a danger-associated molecular pattern (DAMP) in hemolytic diseases. Although localized endothelial barrier (EB) disruption is...
9.
Overexpression of UDP-Glucose 4-Epimerase Is Associated with Differentiation Grade of Gastric Cancer
de Souza M, Filho A, Albuquerque A, Quirino M, de Souza Albuquerque M, Cordeiro M, et al.
Dis Markers
. 2019 Dec;
2019:6325326.
PMID: 31827638
The UDP-glucose 4-epimerase (GALE) is a glycosyltransferase, which acts on protein and lipid glycosylation in normal and neoplastic cells. This study is aimed at investigating the differential tissue expression of...
10.
Batista T, Sobreira M, de Santana R, Arcanjo G, Ramos C, Albuquerque D, et al.
Hematol Transfus Cell Ther
. 2019 May;
41(4):365-368.
PMID: 31126755
No abstract available.